Latest News
Delix in the news
Stay up to date with the latest Delix-related headlines.
july 2023
The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
View Articlefeb 2023
Pioneering Delix Therapeutics Study Published in 'Science' Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity
View Articlefeb 2023
Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability
View ArticleRecent press releases
june 2023
Delix Therapeutics Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in Phase I Trial for Novel Compound DLX-001
View Articleseptember 2022
Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up
View Articleseptember 2022
Delix Therapeutics and Pfizer UK Recognized as Gender Equity Champions for Women in the Workplace by Healthcare Businesswomen's Association
View ArticleSee what else we’ve been up to on LinkedIn.